GJA1 and glioblastoma: Several lines of evidence have indicated that the gap junction protein connexin 43 (Cx43) controls the response of glioblastoma to temozolomide (TMZ) [41], and blocking Cx43 using different approaches restores TMZ sensitivity [42,43].